|
|
|
Dear Customer,
Welcome to a new issue of EMEA News
bringing you
recent
content additions on ScienceDirect and Scopus, usage
driving activities as well as
event and exhibition news from the Europe, Middle East
and Africa (EMEA) region.
In January ScienceDirect added xPharm: the first e-only
and most comprehensive one-stop pharmacology
Online Major Reference Work. Also added to the platform last
month are 45 prestigious medical
Elsevier Masson titles in French language.
Trials available!
Web 2.0 developments have led to the launch of our new collaborative
research tool
2collab
. The Library Connect Newsletter sheds light on the new Web 2.0 world and asks professionals how their library uses 2.0 to reach users.
Find out more about the upcoming
Scopus
Affiliation Identifier , a groundbreaking feature to
allow substantive time saving. We would also like to share with you an initiative of the EMEA Team helping to increase Scopus awareness in your institution -
the
Scopus Quiz.
"If I give you X dollars, what is the
return on investment to the University?" - a study conducted by
Elsevier has just been trying to answer this.
Read the findings.
We hope that you will find
this issue useful and look forward to hearing your feedback and
meeting you at the events.
Thank you.
Best regards,
Maike Wendel
Channel Marketing
Manager
Elsevier EMEA
Team
|
March,
5-8
eBook Fair, Pretoria, South Africa |
March,
6-7
Bibliostar, Milano, Italy |
March,
17-19
Networkshop, Dunaujvaros, Hungary |
March,
17-19
Librarians Information Literacy Annual Conference (LILAC), Liverpool, UK |
April,
3-5
SLA-Arabian Gulf, Manama, Bahrain |
April,
7-9
UKSG, Torquay, UK |
April,
12-16
BioVision Alexandria, Egypt |
|
|
Have you subscribed to these? |
|
 powered by Scopus
is all about Research Performance Measurement
(RPM)!
The
bi-monthly newsletter provides objective,
up-to-minute insights into scientific trends based on
bibliometric analysis.
|
A monthly
e-mail alert informs you each month about the latest topic and
product focused online seminars as well as new and recommended
training resources. |
|
|
xPharm on ScienceDirect |
|
xPharm, the recently launched MRW
on ScienceDirect, is comprised of four searchable and highly
interlinked databases covering molecular Targets, including
receptors, enzymes, transporters and ion channels, chemical
Agents, including both drugs and endogenous compounds, clinical
Disorders, and basic pharmacological Principles. |
 |
It contains over 3,400
individual interlinked records and over 16,000 citations,
equating to over 22,000 printed pages.
Benefits of xPharm on ScienceDirect:
| • |
All articles
will now be available in PDF format in
addition to full-text HTML |
| • |
xPharm is
fully cross-referenced and integrated with
other ScienceDirect content |
| • |
Maintains and
expands cross-reference linking across the
database and via CrossRef to to third-party
platforms |
| • |
Takes full
advantage of ScienceDirect end-user features
such as "Add to Favorites," "Related
Articles," "Email this Article" and more
|
| • |
Executive
Editors Dr S.J. Enna and Dr David Bylund
along with a team of expert Editors and
Associate Editors maintain stringent
editorial oversight |
|
|
|
xPharm will be updated twice
per year and is only available under a subscription model.
To request a 30-day free
trial please contact your
Elsevier Account Manager. Learn more about pricing and
licensing options by visiting the ScienceDirect
Info site. |
|
|
Elsevier Masson titles
on ScienceDirect |
|
|
|
Launch of
2Collab |
| Elsevier has developed and launched a new freely
available research tool enabling researchers to share
bookmarks, references or any linked material with their
peers and collegues. 2collab has been integrated in Scopus
through the "Bookmark"button and the "Add to 2collab" button
in ScienceDirect. |
 |
Visit the 2collab website and
observe, analyse, and learn how researchers use and tag scholarly
data as a community.
 View a short video on 2collab:
Michiel van der Heyden, Senior Product Manager at ScienceDirect,
introduces the tool and demonstrates how it works.
Additionally find more information on Web 2.0 in our
short white paper or the Volume 5
LibraryConnect newsletter. |
|
The Scopus Affiliation
Identifier - Coming Soon! |
|
Scopus continues to
evolve to meet researchers' workflow needs, this time with the
upcoming launch of the
Scopus Affiliation Identifier, becoming the
first tool to identify and match an institute with all its
research output.
With the launch of the
Affiliation Identifier end of April 2008, you and your end users
will easily find all publications from a single institution in just
a few minutes.
Using sophisticated algorithms, the
Scopus Affiliation Identifier will increase the accuracy and speed of
search results by automatically matching and de-duplicating
institute and organization names. This is extremely useful because
several name versions may exist or may be spelled or recorded
differently by individual sources. An institute may also change its
name or have a name similar to another institute. Articles published
by The Massachusetts Institute of Technology, for example, currently
carry more than 1,700 name variants.
Read the full announcement. |
|
Increasing Scopus
Awareness |
Towards the
end of last year the Elsevier EMEA Team prepared an
online quiz to institutions
subscribing to Scopus. Researchers from 16 different
countries were asked to fill in four questions using Scopus
to find the answers. 13 iPod nanos and many CD gift vouchers
were awarded to the winners that gave positive feedback on
the campaign:
"It was a very easygoing way to learn how to use Scopus,
which I have started to do."
"Indeed, I use Scopus since the Quiz much more often."
If you are interested in
having a personalized Scopus Quiz
for your institution contact us at
ChannelMarketing_EMEA@elsevier.com
.
|
Data Protection Notice:
This e-mail has been
sent to none_vci84
from Elsevier B.V., Radarweg 29, 1043 NX Amsterdam, The Netherlands, using
Email Reaction's technology and platform. To ensure delivery to
your inbox (not bulk or junk folders), please click here
to add our address to your safe senders list.
You are receiving this e-mail in the belief that
it will be of interest to you. If you do not wish to receive general
marketing messages from Elsevier B.V., you can unsubscribe here
enter your email address, and press the submit button and you will
be unsubscribed.
Elsevier respects your privacy and does not disclose, sell or rent
your personal information to any non-affiliated third parties without
your consent, except as may be stated in the Elsevier Privacy Policy.
See Email Reaction's Privacy Policy here.
For all enquiries, problems or suggestions regarding this service,
please contact: ChannelMarketing-EMEA@elsevier.com.
Copyright © 2008 Elsevier B.V.
registered office: Radarweg 29, 1043 NX Amsterdam, The Netherlands,
under number 33156677, VAT number 002967455b65. All rights reserved. |
|
